| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |